HIV and aging: effects on the central nervous system.
With the introduction of combination antiretroviral therapy, many human immunodeficiency virus-positive (HIV+) individuals are reaching advanced age. The proportion of people living with HIV older than 50 years already exceeds 50% in many communities, and is expected to reach this level nationally by 2015. HIV and aging are independently associated with neuropathological changes, but their concurrence may have a more deleterious effect on the central nervous system (CNS). Published data about neurocognitive and neuroimaging markers of HIV and aging are reviewed. Putative factors contributing to neurocognitive impairment and neuroimaging changes in the aging HIV+ brain, such as metabolic disturbances, cardiovascular risk factors, immune senescence, and neuroinflammation, are described. The possible relationship between HIV and some markers of Alzheimer's disease is presented. Current research findings emphasize multiple mechanisms related to HIV and combination antiretroviral therapy that compromise CNS structure and function with advancing age.
Clinical Institute of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain.
Silvia
S
Cañizares
Department of Psychiatry, University of California, San Diego, California.
Mariana
M
Cherner
Department of Neurosciences, HIV Neurobehavioral Research Center, University of California, San Diego, California.
Ronald J
RJ
Ellis
D000375:Aging; D002493:Central Nervous System Diseases / Q000209:etiology* / Q000821:virology*; D015658:HIV Infections / Q000150:complications*; D006801:Humans